Constitutive activation of stimulatory guanine nucleotide binding protein (G(s)αQL)-mediated signaling increases invasiveness and tumorigenicity of PC-3M prostate cancer cells

Oncogene

Volumn 18, Issue 22, 1999, Pages 3376-3382

  Chien, J ^a   Wong, E ^b   Nikes, E ^a   Noble, M J ^a   Pantazis, C G ^b   Shah, G V ^a,c  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

G(s) ; Invasiveness; Prostate cancer; Tumorigenicity

Indexed keywords

AGAR; COMPLEMENTARY DNA; MUTANT PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CANCER INVASION; CARCINOGENICITY; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; ORGAN WEIGHT; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; CARCINOGENICITY TESTS; CARCINOMA; CELL MOVEMENT; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MUTATION; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0005982599     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202690     Document Type: Article

References (42)

1. Abdul M, Anezinis PE, Logothetis CJ and Hoosein NM. (1994). Anticancer Res., 14, 1215-1220.
2. Aprikian AG, Cordon Cardo C, Fair WR, Zhang ZF, Bazinet M, Hamdy SM and Reuter VE. (1994). J. Urol., 151, 914-919.
3. Aprikian AG, Han K, Chevalier S, Bazinet M and Viallet J. (1996). J. Mol. Endocrin., 16, 297-306.
4. Banerjee A, Xu HJ, Hu SX, Araujo D, Takahashi R, Stanbridge EJ and Benedict WR. (1992). Cancer Res., 52, 6297-6304.
5. Carmena MJ, Garcia-Paramio P, Solano RM and Prieto JC. (1995). Prostate, 27, 204-211.
6. Chen C, Poulin R and Labrie F. (1996). J. Steroid Biochem. Mol. Biol., 58, 489-494.
7. Clapham DE. (1993). Cell, 75, 1237-1239.
8. Cohen MK, Arber DA, Coffield KS, Keegan GT, McClintock J and Speights VOJ. (1994). Cancer, 74, 1899-1903.
9. di Sant'Agnese PA. (1992). Cancer, 70, 254-268.
10. Drews RT, Gravel RA and Collu R. (1992). Mol. Cell Endocrinol., 87, 125-129.
11. Faure M and Bourne HR. (1995). Mol. Biol. Cell., 6, 1025-1035.
12. Gaiddon C, Boutillier AL, Monnier D, Mercken L and Loeffler JP. (1994). J. Biol. Chem., 269, 22663-22671.
13. Gup DI, Shapiro E, Baumann M and Lepor H. (1990). J. Urol., 143, 179-185.
14. Hoosein NM, Logothetis CJ and Chung LW. (1993). J. Urol., 149, 1209-1213.
15. Huang ZY, Meng FQ and Chen H. (1994). Chung, Hua, I, Hsueh, Tsa, Chih., 74, 23-25.
16. Juarranz MG, Guijarro LG, Bajo AM, Carmena MJ and Prieto JC. (1994). Gen. Pharmacol., 25, 509-514.
17. Kadmon D, Thompson TC, Lynch GR and Scardino PT. (1991). J. Urol., 146, 358-361.
18. Killam AL, Watts SW and Cohen ML. (1995). Eur. J. Pharmacol., 273, 7-14.
19. Langer DJ, Kuo A, Kariko K, Ahuja M, Klugherz BD, Ivanics KM, Hoxie JA, Williams WV, Liang BT and Cines DB. (1993). Circ. Res., 72, 330-340.
20. Lefkowitz RJ. (1993). Nature, 365, 603-604.
21. Lepor H and Kuhar MJ. (1984). J. Urol., 132, 397-402.
22. Logothetis C and Hoosein N. (1992). J. Cell. Biochem., 16 (Suppl.), H128-H134.
23. Logothetis CJ, Hoosein NM and Hsieh JT. (1994). Semin. Oncol., 21, 620-629.
24. Lopez-Ilasaca M, Li W, Uren A, Yu JC, Kazlauskas A, Gutkind JS and Heidaran MA. (1997). Biochem. Biophys. Res. Commun., 232, 273-277.
25. Mira-y-Lopez R, Jaramillo S and Waxman S. (1992). J. Biol. Chem., 267, 23063-23068.
26. Muca C and Vallar L. (1994). Oncogene, 9, 3647-3653.
27. Murga C, Laguinge L, Wetzker R, Cuadrado A and Gutkind JS. (1998). J. Biol. Chem., 273, 19080-19085.
28. Newling DW. (1992). Prostate, 4 (Suppl.), 139-143.
29. Newling DW. (1996). Eur. Urol., 29 (Suppl. 2), 69-74.
30. Rayford W, Noble MJ, Austenfeld MA, Weigel J, Mebust WK and Shah GV. (1997). Prostate, 30, 160-166.
31. Reubi JC. (1995). J. Nucl. Med., 36, 1846-1853.
32. Segal NH, Cohen RJ, Haffejee Z and Savage N. (1994). Arch. Pathol. Lab. Med., 118, 616-618.
33. Shah GV, Rayford W, Nobel MJ, Austenfeld M, Weigel J, Vamos S and Mebust WK. (1994). Endocrinology, 134, 596-602.
34. Shintani Y, Yoshimoto K, Horie H, Sano T, Kanesaki Y, Hosoi E, Yokogoshi Y, Bando H, Iwahana H and Kannuki S. (1995). Endocrin. J., 42, 331-340.
35. Solano RM, Carmena MJ, Guijarro LG and Prieto JC. (1994). Neuropeptides, 27, 31-37.
36. Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG and Prieto JC. (1996). Endocrinology, 137, 2815-2822.
37. Stephenson RA, Dinney CPN, Gohji K, Ordonez NG, Killion JJ and Fidler IJ. (1992). J. NCI, 84, 951-957.
38. Tanaka K, Iwamoto Y, Ito Y, Ishibashi T, Nakabeppu Y, Sekiguchi M and Sugioka Y. (1995). Cancer Res., 55, 2927-2935.
39. van Weerden WM, Moerings EP, van Kreuningen A, de Jong FH, van Steenbrugge GJ and Schroder FH. (1993). Cell Prolif., 26, 67-75.
40. Wu G, Burzon DT, di Sant'Agnese PA, Schoen S, Deftos LJ, Gershagen S and Cockett AT. (1996). Urology, 47, 376-381.
41. Young MR, Montpetit M, Lozano Y, Djordjevic A, Devata S, Matthews JP, Yedavalli S and Chejfee G. (1995). Int. J. Cancer, 61, 104-109.
42. Zeiger MA and Norton JA. (1993). Surgery, 114, 458-462.